TE_134

Basic information Differential Expression Stage analysis Survival analysis Correlation analysis

TE family MLT1H
TE superfamily MaLR
TE class LTR
Gene -
Class Intergenic
Coding Non-coding
Tumor-specific score 2.73
Counts of samples TCGA_tumor:130; TCGA_normal:5; GTEx:48
TSS chr1(-):15340494



Transcript isoforms

Transcript_ID Gene Class Coding ORF Position
teRNA_134.1 - Intergenic Non-coding Non-coding chr1(-):15338433,15338453,15338796,15338963,15340380,15340495
teRNA_134.2 - Intergenic Non-coding Non-coding chr1(-):15338574,15338594,15338796,15338963,15340380,15340495
teRNA_134.3 - Intergenic Non-coding Non-coding chr1(-):15338433,15338453,15338796,15338941,15340380,15340495
teRNA_134.4 - Intergenic Non-coding Non-coding chr1(-):15338433,15338453,15338796,15338963,15339455,15339506,15340380,15340495
teRNA_134.5 - Intergenic Non-coding Non-coding chr1(-):15338433,15338453,15338796,15338963,15339455,15339594,15340380,15340495


GTEx

The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.




TCGA

The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).




GTEx

The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.




TCGA

The expression of TE-initiated transcript across 33 cancer types from The Cancer Genome Atlas (TCGA).